RXRXNasdaq United States
Market cap
$1.724 B
$3.22 +1.26%
Close of 7 Aug 2026
Revenue
$74.7M
#2617 by revenue
Earnings
-$644.8M
Loss-making
Shares outstanding
535,342,170
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for Recursion Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.